CorriXR Therapeutics

Website

Operator of a gene editing company, intended to develop therapeutics and treat cancer using CRISPR technology, met with the FDA to discuss plans for a clinical trial. The company's platform technology...

Healthcare
Newark, DE, United States
Founded 2022
5 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$25M
Last Round
N/A
Investors
+6 other investors
View all 6 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock CorriXR Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required